Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome

Objective Both oral contraceptive pills (OCPs) and cyclic medroxyprogesterone acetate (MPA) are widely used to control menstrual abnormalities in women with polycystic ovary syndrome (PCOS). We aimed to evaluate the chance of ovulation resumption after cessation of OCPs and MPA in women with PCOS.Me...

Full description

Saved in:
Bibliographic Details
Main Authors: Soo Jin Han, Hoon Kim, Seung-Yup Ku, Chang Suk Suh
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Gynecological Endocrinology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09513590.2024.2309349
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850104248632606720
author Soo Jin Han
Hoon Kim
Seung-Yup Ku
Chang Suk Suh
author_facet Soo Jin Han
Hoon Kim
Seung-Yup Ku
Chang Suk Suh
author_sort Soo Jin Han
collection DOAJ
description Objective Both oral contraceptive pills (OCPs) and cyclic medroxyprogesterone acetate (MPA) are widely used to control menstrual abnormalities in women with polycystic ovary syndrome (PCOS). We aimed to evaluate the chance of ovulation resumption after cessation of OCPs and MPA in women with PCOS.Methods A retrospective study was conducted of women with PCOS who were treated with OCPs or cyclic MPA from September 2015 to March 2019. After cessation of medication, ovulation was assessed using basal body temperature and/or measurement of serum progesterone. The odds ratio for ovulation resumption was assessed with multivariable logistic regression. Additionally, doubly robust analysis was performed with inverse-probability-weighted analysis and regression adjustment based on the covariate balancing propensity score to adjust for the effect of covariates on the treatment assignment.Results Among 272 women with PCOS, 136 were prescribed OCPs and 136 were prescribed cyclic MPA. Ovulation resumed in 18.4% of women (n = 25) after cessation of MPA and in 24.3% of women (n = 33) after cessation of OCPs. The odds of ovulation resumption in MPA users were comparable with those in OCP users (adjusted odds ratio (aOR) 1.00, 95% confidence interval (CI) 0.89–1.12). After multiple imputation due to missing values, the results did not change substantially (aOR 0.99, 95% CI 0.89–1.10).Conclusions Among women with PCOS, MPA users have a similar chance of ovulation resumption as OCP users after cessation of medication. Cyclic MPA can be a good alternative to OCPs in women for whom OCPs are contraindicated or who decline to take OCPs.
format Article
id doaj-art-c587409b172a449c9bb0a860f74a044c
institution DOAJ
issn 0951-3590
1473-0766
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Gynecological Endocrinology
spelling doaj-art-c587409b172a449c9bb0a860f74a044c2025-08-20T02:39:22ZengTaylor & Francis GroupGynecological Endocrinology0951-35901473-07662024-12-0140110.1080/09513590.2024.2309349Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndromeSoo Jin Han0Hoon Kim1Seung-Yup Ku2Chang Suk Suh3Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, KoreaDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, KoreaDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, KoreaDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, KoreaObjective Both oral contraceptive pills (OCPs) and cyclic medroxyprogesterone acetate (MPA) are widely used to control menstrual abnormalities in women with polycystic ovary syndrome (PCOS). We aimed to evaluate the chance of ovulation resumption after cessation of OCPs and MPA in women with PCOS.Methods A retrospective study was conducted of women with PCOS who were treated with OCPs or cyclic MPA from September 2015 to March 2019. After cessation of medication, ovulation was assessed using basal body temperature and/or measurement of serum progesterone. The odds ratio for ovulation resumption was assessed with multivariable logistic regression. Additionally, doubly robust analysis was performed with inverse-probability-weighted analysis and regression adjustment based on the covariate balancing propensity score to adjust for the effect of covariates on the treatment assignment.Results Among 272 women with PCOS, 136 were prescribed OCPs and 136 were prescribed cyclic MPA. Ovulation resumed in 18.4% of women (n = 25) after cessation of MPA and in 24.3% of women (n = 33) after cessation of OCPs. The odds of ovulation resumption in MPA users were comparable with those in OCP users (adjusted odds ratio (aOR) 1.00, 95% confidence interval (CI) 0.89–1.12). After multiple imputation due to missing values, the results did not change substantially (aOR 0.99, 95% CI 0.89–1.10).Conclusions Among women with PCOS, MPA users have a similar chance of ovulation resumption as OCP users after cessation of medication. Cyclic MPA can be a good alternative to OCPs in women for whom OCPs are contraindicated or who decline to take OCPs.https://www.tandfonline.com/doi/10.1080/09513590.2024.2309349Polycystic ovary syndromeovulationoral contraceptive pillsmedroxyprogesterone acetate
spellingShingle Soo Jin Han
Hoon Kim
Seung-Yup Ku
Chang Suk Suh
Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
Gynecological Endocrinology
Polycystic ovary syndrome
ovulation
oral contraceptive pills
medroxyprogesterone acetate
title Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
title_full Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
title_fullStr Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
title_full_unstemmed Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
title_short Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
title_sort comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
topic Polycystic ovary syndrome
ovulation
oral contraceptive pills
medroxyprogesterone acetate
url https://www.tandfonline.com/doi/10.1080/09513590.2024.2309349
work_keys_str_mv AT soojinhan comparisonofresumptionofovulationaftercessationoforalcontraceptivesandmedroxyprogesteroneacetateinwomenwithpolycysticovarysyndrome
AT hoonkim comparisonofresumptionofovulationaftercessationoforalcontraceptivesandmedroxyprogesteroneacetateinwomenwithpolycysticovarysyndrome
AT seungyupku comparisonofresumptionofovulationaftercessationoforalcontraceptivesandmedroxyprogesteroneacetateinwomenwithpolycysticovarysyndrome
AT changsuksuh comparisonofresumptionofovulationaftercessationoforalcontraceptivesandmedroxyprogesteroneacetateinwomenwithpolycysticovarysyndrome